1. Home
  2. HTCR vs SILO Comparison

HTCR vs SILO Comparison

Compare HTCR & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartcore Enterprises Inc.

HTCR

Heartcore Enterprises Inc.

N/A

Current Price

$1.77

Market Cap

2.7M

Sector

Technology

ML Signal

N/A

Logo Silo Pharma Inc.

SILO

Silo Pharma Inc.

N/A

Current Price

$1.41

Market Cap

3.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
HTCR
SILO
Founded
2009
2010
Country
Japan
United States
Employees
N/A
N/A
Industry
EDP Services
Apparel
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
3.1M
IPO Year
2022
2011

Fundamental Metrics

Financial Performance
Metric
HTCR
SILO
Price
$1.77
$1.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.1K
★ 44.0K
Earning Date
11-17-2026
11-12-2026
Dividend Yield
★ 145.25%
N/A
EPS Growth
★ 414.29
57.98
EPS
N/A
★ N/A
Revenue
★ $30,407,229.00
$72,102.00
Revenue This Year
$118.88
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 39.19
N/A
52 Week Low
$0.15
$0.22
52 Week High
$3.97
$7.95

Technical Indicators

Market Signals
Indicator
HTCR
SILO
Relative Strength Index (RSI) 29.99 20.83
Support Level N/A N/A
Resistance Level $2.16 $4.80
Average True Range (ATR) 0.12 0.11
MACD -0.02 0.04
Stochastic Oscillator 19.61 27.00

Price Performance

Historical Comparison
HTCR
SILO

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company providing solutions for digital transformation (DX). It develops, sells, and maintains CMS and CXM platforms using digital marketing technology, RPA, process mining solutions, myInvenio and Apromore, task mining solution CONTROLIO, and 3D-VR services including Matterport and VR360. The company also provides management consulting, education, services, and support to help customers succeed with the CXM Platform. It operates through two business units, the CX division for customer experience management and the DX division for digital transformation, which provides robotics process automation, process mining, and task mining. Its products include VR360, myInvenio, Apromore, and others, with maximum revenue from the United States.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.

Share on Social Networks: